Radiation plus combination immunotherapy may help preserve bladder in some patients with cancer

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to results from the IMMUNOPRESERVE clinical trial published in Clinical Cancer Research.

Frailty score could reduce pressure on hospital beds and lower costs

The Hospital Frailty Risk Score (HFRS) helps identify older patients (aged 75 and over) who may be frail and more likely to experience poor outcomes during or after a hospital stay. New research, led by the University of Portsmouth in collaboration with Portsmouth Hospitals University NHS Trust, has found the HFRS is effective at predicting extended hospital stays in patients of all ages—not just older adults.